Cite
HARVARD Citation
Wang, Y. et al. (2022). Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β‐cell function in nonhuman primate model of diabetes. Fundamental & clinical pharmacology. pp. 699-711. [Online].